Aligos Therapeutics Inc (NASDAQ:ALGS)
| 1.44 Delayed Data As of 3:59pm ET |  +0.04 / +2.86%Today’s Change | 1.03 Today|||52-Week Range 17.97 | -87.87% Year-to-Date |
Latest ALGS News | Press Releases
No recent news for Aligos Therapeutics Inc.
Today’s Trading
| Previous close | 1.40 |
| Today’s open | 1.43 |
| Day’s range | 1.41 - 1.45 |
| Volume | 1,988 |
| Average volume (3 months) | 282,554 |
| Market cap | $64.5M |
Data as of 3:59pm ET, 08/12/2022
Growth & Valuation
| Earnings growth (last year) | -8.59% |
| Earnings growth (this year) | +25.78% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 108.53 |
| Price/Book | 0.35 |
Competitors
| No competitors data available. |
Financials
| Next reporting date | November 3, 2022 |
| EPS forecast (this quarter) | -$0.58 |
| Annual revenue (last year) | $4.4M |
| Annual profit (last year) | -$128.3M |
| Net profit margin | -2,944.07% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters --, -- |
Forecasts
